Aller au contenu principal
Accès ouvert déclaré 2024 article

Genexpert MTB/RIF Contribution to the Diagnosis of Pulmonary Tuberculosis in People Living with HIV at the Siguiri Prefectural Hospital (Republic of Guinea)

1Citations signalées — pas une note de qualité
2Institutions déclarées
2Pays d’affiliation déclarés

Résumé fourni par la source

Introduction: Tuberculosis (TB) is an infectious disease transmitted from person to person and caused by the bacillus Koch (BK).It is a major public health problem throughout the world, despite the numerous tuberculosis control strategies (TCS).Objective: To evaluate the value of Genexpert MTB/RIF in the diagnosis of pulmonary tuberculosis in PLHIV at Siguiri prefectural hospital, with a view to improving patient care.Method: This is a prospective, descriptive, cross-sectional study lasting six months, from 15 February to 15 August 2023.Results: Biological diagnosis of 200 patients revealed 85 Genexpert-positive patients, i.e. a prevalence of 42.5%, compared with 79 fluorescence microscopy-positive patients, i.e. 39.5%.The variation in viral load in the 85 patients tested positive for HIV-TB coinfection was significant in HIV-TB co-infected patients with a mean of (59277copies/ml).Immunosuppression was advanced overall, with the majority of patients in our study having an LTCD4+ level of less than 200 cells/µl.The mean LTCD4+ level was 124.52 cells/ µl, with extremes ranging from 5 to 349 cells/µl.Patients with a mean LTCD4+ level ≥ 200 cells/µl accounted for 72% of cases.Married patients were the most represented at 62%, the majority being blue-collar workers (42%), followed by housewives (19%).The 31-40 age group was the most affected, with a prevalence of 31%.The Siguiri Koura 1 and 2 neighbourhoods were the most affected by HIV-MTB co-infection, with 26% and 21% respectively.Conclusion: The present study proves that the Genexpert MTB/RIF method is the best method for diagnosing pulmonary tuberculosis compared with Microscopy (Fluorescence and Ordinary) and plays a major role in predicting multi-drug resistance, particularly to Rifampicin, in Mycobacterium tuberculosis.Its systematic use in conjunction with.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Genexpert MTB/RIF Contribution to the Diagnosis of Pulmonary Tuberculosis in People Living with HIV at the Siguiri Prefectural Hospital (Republic of Guinea)
Date Crossref
01/07/2024
Éditeur
Acta Scientific Publications Pvt. Ltd.
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Tuberculosis Research and EpidemiologyDiagnosis and treatment of tuberculosis

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.